CClinicalTrials.gg
CompletedNCT07245758Updated Apr 22, 2026

Facial iD Customized Mandible Reconstruction Plates

An observational study in Mandibular Fractures, Mandible Fracture and Mandible; Deformity, sponsored by Stryker Craniomaxillofacial. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Stryker Craniomaxillofacial · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
50
Sex
All
01

Study summary

A retrospective post market follow up to confirm the safety and performance of Stryker's Customized Plates for Mandibular Reconstruction. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Read the detailed description

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker Customized Plates for Mandibular Reconstruction (CMRP) in the clinical setting. his study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively. The Customized Mandible Recon Plate Kit is indicated for use in primary mandibular reconstruction with bone graft, temporary bridging until delayed secondary reconstruction and secondary mandibular reconstruction. Up to 3 investigational sites in US will be participating. Based on a non-inferiority study power calculation 80 subjects will be enrolled in the study. The primary outcome parameter evaluating successful reconstruction of the mandible without the need for unplanned revision surgery will be evaluated at all available follow-up timepoints of the included patients.

02

Conditions studied

  • Mandibular Fractures
  • Mandible Fracture
  • Mandible; Deformity
  • MANDIBLE
  • Orthognathic Surgical Procedures

Keywords

  • Mandibular Reconstruction
  • Reconstruction Plate
  • Orthognathic Surgery
  • Mandibular Reconstruction* / Methods
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Eligible patients will be identified as having had a surgical procedure involving the Subject Device.

Inclusion criteria

  1. Patients who underwent primary or secondary mandibular reconstruction using a Stryker Facial iD CMRP implant as per routine clinical practice.
  2. Patients for whom data on the primary outcome variable is available.

Exclusion criteria

Exclusion Criteria:

  1. Patients with active local infections at the time of surgery
  2. Patients with known metal allergies and/or foreign body sensitivity at the time of surgery
  3. Potentially non-compliant patients who were unwilling or incapable of following post-operative care instructions
  4. Patients with inadequate bone quantity or quality necessary for plate fixation or stabilization at the time of surgery
04

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
50 participants (actual)
Patient registry
No

Interventions

  • DeviceMandibular reconstruction

    Primary or secondary reconstruction of the mandible using customized Mandible Reconstruction Plate (referred to as CMRP)

05

What researchers measure

Primary outcomes

  1. Rate of successful reconstruction of the mandible without the need for unplanned revision surgery

    Rate of unplanned revision surgery determined by reviewing adverse events in patient medical charts after surgery. Used to document whether an unplanned revision surgery was required or not for each patient.

    Time frame: Data collected at a single time point per patient in the course of 16 months

Secondary outcomes

  1. Rate of satisfactory occlusion achieved with orthodontic treatment.

    Assessed by review of individual patient medical records that document the rate of satisfactory occlusion achieved with orthodontic treatment.

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  2. Infection rate

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at time points from patient medical charts in the course of 16 months.

  3. Intraoperative complications

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  4. Postoperative complications

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at time points per patient in the course of 16 months.

  5. Any known adverse events

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at time points per patient in the course of 16 months.

  6. Rate of plate or screw failure

    Determined by rate of adverse events reported from patient medical charts involving plate or screw fracture.

    Time frame: Data collected at time points point per patient in the course of 16 months.

  7. Operating room (OR) time

    Time patients are operated (dd:hh)

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  8. Time to return to solid food/normal diet

    Time for patient to return to solid food/normal diet post operation (dd)

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  9. Hospitalization time: ICU and normal ward

    Time the patient was hospitalized post procedure (dd:hh)

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  10. EuroQol-5 Domain Questionnaire (if available)

    A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).

    Time frame: Data collected at time points per patient in the course of 16 months.

  11. End user questionnaire

    Questionnaire only for medically trained professionals on site staff using the device. Questions relate to subjective rating of ease of use by the surgeon if compared to stock plates (evaluated per treating surgeon, not per patient). Questionnaire is qualitative response regarding the ease of use of the device.

    Time frame: Data collected during the course of 16 months.

  12. Misfit of implant

    Fit of implant Time for adaptations

    Time frame: Data collected at time points per patient in the course of 16 months.

  13. Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)

    40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.

    Time frame: Data collected at time points per patient in the course of 16 months.

  14. 12-Item Short Form Health Survey (SF-12)

    12 items grouped and scored to produce two separate summary scores: the Physical Component Summary (PCS-12) and the Mental Component Summary (MCS-12). The scale is transformed to a 0-100 range with higher scores indicating better health.

    Time frame: Data collected at time points per patient in the course of 16 months.

  15. Visual Analogue Scale (VAS) Pain

    The visual analogue scale (VAS) is a psychometric response scale. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). 100-mm VAS ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain.

    Time frame: Data collected at time points per patient in the course of 16 months.

  16. Ischemia time

    Ischemia time (dd:hh)

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  17. Frequency of Maxilla-mandibular fixation

    Number of maxillo-mandibular fixation procedures (number per patient).

    Time frame: Data collected at time points per patient in the course of 16 months.

Other outcomes

  1. Follow-up time

    Post operative follow up time for patients within standard of care. Reported in patient medical charts during hospital follow up visits.

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  2. Flap used

    Type of flap used: vascularized fibula flap, vascularized scapula flap, vascularized iliac crest flap, avascularized fibula flap, avascularized scapula flap, avascularized iliac crest flap, others

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  3. Radiation

    Exposure of patient to radiation therapy within 12 months around the surgery date recorded in patient medical charts. Radiation therapy performed on the anatomical area treated with the device. Any postoperative radiation therapy recorded in patient medical charts.

    Time frame: Data collected at time points per patient in the course of 16 months.

  4. Dental reconstruction in a single stage surgery

    Data for dental reconstruction collected from patient medical charts.

    Time frame: Data collected at time points per patient in the course of 16 months.

  5. Sterilization method used

    Sterilization method used for the device.

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  6. Fixation system used

    System used to fix the device during the procedure. Stryker Universal Mandible System; other Types and number of screws

    Time frame: Data collected at a single time point per patient in the course of 18 months.

  7. Plate types

    2.0 or 2.8 plates used Hemi or full reconstruction plate used

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  8. Patient age

    Age (years)

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  9. Gender

    Responses: Male, Female, undifferentiated, unknown

    Time frame: Data collected at a single time point per patient in the course of 16 months

  10. Primary indication for the surgery / diagnosis

    Diagnosis collected from patient medical charts.

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  11. Surgical approach

    Surgical approach taken for the procedure. Including: transoral; transbuccal; submandibular; preauricular; other

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  12. Relevant Medical conditions

    Descriptive data of any underlying medical conditions and medications recorded in patient medical charts that may be related to the device or primary outcome (qualitative measure).

    Time frame: Data collected at time points per patient in the course of 16 months.

  13. Primary/secondary reconstruction performed

    Type of reconstruction procedure performed (e.g. immediately or after an initial surgery).

    Time frame: Data collected at time points point per patient in the course of 16 months

  14. Localization of the defect

    Area to treated by the device: mandibular ramus; mandibular body; mandibular condyle; parasymphysis; paramedian; other

    Time frame: Data collected at time points point per patient in the course of 16 months.

  15. Patient height

    Height (cm, feet, inches)

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  16. Patient weight

    Weight (kg, lb)

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  17. Year smoking was stopped

    Year smoking was stopped (YYYY)

    Time frame: Data collected at time points per patient in the course of 16 months.

  18. Smoking frequency

    The frequency of exposure to smoking during periods of smoking (average number of cigarettes per day).

    Time frame: Data collected at time points per patient in the course of 16 month

  19. Smoking duration

    Duration of smoking (pack years)

    Time frame: Data collected at time points per patient in the course of 16 month

  20. Years of active smoking

    Total number of years active smoker (YY)

    Time frame: Data collected at time points per patient in the course of 16 month

06

Study locations

1 site
  • Head & Neck Surgery Medical University of South Carolina
    Charleston, South Carolina 29403, United States
07

References and documents

Publications

  • van Baar GJC, Forouzanfar T, Liberton NPTJ, Winters HAH, Leusink FKJ. Accuracy of computer-assisted surgery in mandibular reconstruction: A systematic review. Oral Oncol. 2018 Sep;84:52-60. doi: 10.1016/j.oraloncology.2018.07.004. Epub 2018 Jul 20. PubMed 30115476 ↗
  • Mollmann HL, Apeltrath L, Karnatz N, Wilkat M, Riedel E, Singh DD, Rana M. Comparison of the Accuracy and Clinical Parameters of Patient-Specific and Conventionally Bended Plates for Mandibular Reconstruction. Front Oncol. 2021 Nov 26;11:719028. doi: 10.3389/fonc.2021.719028. eCollection 2021. PubMed 34900674 ↗
  • Witjes MJH, Schepers RH, Kraeima J. Impact of 3D virtual planning on reconstruction of mandibular and maxillary surgical defects in head and neck oncology. Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):108-114. doi: 10.1097/MOO.0000000000000437. PubMed 29470184 ↗
  • Lee ZH, Alfonso AR, Ramly EP, Kantar RS, Yu JW, Daar D, Hirsch DL, Jacobson A, Levine JP. The Latest Evolution in Virtual Surgical Planning: Customized Reconstruction Plates in Free Fibula Flap Mandibular Reconstruction. Plast Reconstr Surg. 2020 Oct;146(4):872-879. doi: 10.1097/PRS.0000000000007161. PubMed 32590512 ↗
  • Kakarala K, Shnayder Y, Tsue TT, Girod DA. Mandibular reconstruction. Oral Oncol. 2018 Feb;77:111-117. doi: 10.1016/j.oraloncology.2017.12.020. Epub 2018 Jan 4. PubMed 29362116 ↗
08

Registry details

Key details

Study ID
NCT07245758
Lead sponsor
Stryker Craniomaxillofacial
Responsible party
Sponsor
First posted
Nov 24, 2025
Start date
Dec 1, 2024
Primary completion
Apr 4, 2026
Completion
Apr 4, 2026
Last update
Apr 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion